Document is current
Any future updates will be listed below
-
Authors
Georgiev, Tony https://orcid.org/0000-0001-8888-7096
Migliorini, Francesca
Ciamarone, Andrea https://orcid.org/0009-0001-7841-1964
Mueller, Marco https://orcid.org/0009-0009-7277-1246
Biancofiore, Ilaria https://orcid.org/0000-0001-8567-9013
Faviana, Pinuccia
Bartoli, Francesco https://orcid.org/0000-0002-2702-3259
Park Kim, Young Seo
Principi, Lucrezia
Gilardoni, Ettore https://orcid.org/0000-0002-2010-2667
Bassi, Gabriele
Favalli, Nicholas https://orcid.org/0000-0002-6538-7379
Puca, Emanuele
Neri, Dario
Oehler, Sebastian https://orcid.org/0000-0003-2013-7381
Cazzamalli, Samuele https://orcid.org/0000-0003-0510-5664
- License Information
-
More Information
Article History
Received: 8 March 2024
Accepted: 19 May 2025
First Online: 26 June 2025
Competing interests
: D.N. is the co-founder, CEO, CSO and president of the Scientific Advisory Board of Philogen. T.G., F.M., I.B., M.M., Y.S.P.K., L.P., E.G., N.F., E.P., S.O. and S.C. are employed by Philochem AG, the research and development unit of the Philogen group. Some of the findings included in this manuscript have been patented. T.G., F.M., S.O., S.C., D.N. and Y.S.P.K. are listed in the patent application PCT/EP2024/080350 (filed on 25 October 2024). The other authors declare no competing interests.
